Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharm II > CNS, ANS > Flashcards

CNS, ANS Flashcards

1
Q

Adjunctive anaesthetic drugs

A

Drugs used in combination with anaesthetic drugs to control the adverse effects of anaesthetics or to help maintain the anaesthetic state in the patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Anaesthesia

A

Loss of the ability to feel pain, resulting from the administration of an anaesthetic drug or other medical intervention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Anaesthetics

A

Drugs that depress the central nervous system (CNS) to produce diminution of consciousness, loss of responsiveness to sensory stimulation, or muscle relaxation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Balanced Anaesthesia

A

The practice of using combination of drugs rather than a single drug to produce anaesthesia. A common combination is a mixture of sedative-hypnotic, an anti anxiety drug, an analgesic, an antiemetic, and an anticholinergic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

General Anaesthesia

A

A drug-induced state in which the CNS is altered to produce varying degrees of pain relief throughout the body as well as depression of consciousness, skeletal muscle relaxation, and diminished or absent reflexes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

General Anaesthetic

A

A drug that induces a state of anaesthesia. Its effects are global in that it involves the whole body, with loss of consciousness being one of those effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Local anaesthetics

A

Drugs that render a specific portion of the body insensitive to pain at the level of the peripheral nervous system, normally without affecting consciousness; also called regional anaesthetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Malignant Hyperthermia

A

A genetically linked major adverse reaction to general anaesthesia, characterized by a rapid rise in body temperature, as well as tachycardia, tachypnea, and sweating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Minimum alveolar concentration

A

The minimal concentration of the gas in the lungs that is needed to provide anaesthesia in 50% of subjects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Moderate sedation

A

A form of anaesthesia induced by combinations of parenteral benzodiazepines and an opiate; also called conscious sedation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Overton-Meyer theory

A

A theory that describes the relationship between the lipid solubility of anaesthetic drugs and their potency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Parenteral Anaesthetics

A

Any anaesthetic drugs that can be administered by injection via any route (IV, spinally, epidurally) as a local nerve block

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Topical Anaesthetics

A

A class of local anaesthetics consisting of solutions, ointments, gels, creams, powders, ophthalmic drops, and suppositories that are applied directly to the skin and mucous membranes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Anxiolytic

A

A medication that relieves anxiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Barbiturates

A

A class of drugs that are chemical derivatives of barbituric acid. They can induce sedation and sleep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Benzodiazepines

A

A chemical category of drugs most frequently prescribed as sedative-hypnotic and anxiolytic drugs; the most common group of psychotropic drugs currently prescribed to alleviate anxiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Gamma-aminobutyric acid (GABA)

A

An inhibitory neurotransmitter found in the brain that functions to inhibit nerve transmission in the CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Hypnotics

A

Drugs that, when given at low to moderate doses, calm or sooth the CNS without inducing sleep but when given at high doses may cause sleep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Non-rapid eye movement (Non-REM) sleep

A

One of the stages of the sleep cycle. It characteristically has four stages and precedes REM sleep. Most of a normal sleep cycle consists of non-REM sleep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Rapid-eye movement (REM) sleep

A

One of the stages of the sleep cycle. Some of the characteristics of REM sleep are rapid movement of the eyes, vivid dreams, and irregular breathing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

REM interference

A

A drug-induced reduction of REM sleep time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

REM rebound

A

Excessive REM sleep following discontinuation of a sleep-altering drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Sedatives

A

Drugs that have an inhibitory effect on the CNS to the degree that they reduce nervousness, excitability, and irritability without causing sleep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Sedative-hypnotics

A

Drugs that can act in the body either as sedatives or hypnotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Sleep

A

A transient, reversible, and periodic state of rest in which there is a decrease in physical activity and consciousness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Sleep architecture

A

The structure of the elements involved in the sleep cycle, including normal and abnormal patterns of sleep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Tachyphylaxis

A

The rapid appearance of a progressive decrease in response to a drug after repetitive administration of the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Therapeutic index

A

The ratio between the toxic and therapeutic concentrations of a drug. If the index is low, the difference between the therapeutic and toxic drug concentrations is small, and use of the drug is more hazardous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Anticonvulsant

A

A substance or procedure that prevents or reduces the severity of epileptic or other convulsive seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Antiepileptic drug

A

A substance that prevents or reduces the severity of epilepsy and different types of epileptic seizures, not just convulsive seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Autoinduction

A

A metabolic process that occurs when a drug increases its own metabolism over time, leading to lower than expected drug concentrations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Convulsion

A

A type of seizure involving excessive stimulation of neurone in the brain and characterized by the spasmodic contraction of voluntary muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Epilepsy

A

General term for any of a group of neurological disorders characterized by recurrent episodes of convulsive seizures, sensory disturbances, abnormal behaviour, loss of consciousness, or any combination of these

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

International Classification of Seizures

A

The most extensively used system of classifying seizures, including the symptoms and characteristics of each type of seizure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Narrow therapeutic index (NTI) drugs

A

Drugs that are characterized by a narrow difference between their therapeutic and toxic doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Primary or idiopathic epilepsy

A

Epilepsy that develops without an apparent cause. More than 50% of cases of epilepsy are of unknown origin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Secondary epilepsy

A

Epilepsy that has a distinct cause (trauma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Seizure

A

Extensive stimulation of neurone in the brain leading to a sudden burst of abnormal neurone activity tat results in temporary changes in brain function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Status Epilepticus

A

A common seizure disorder characterized by generalized tonic-clonic convulsions that occur in succession

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Tonic-clonic seizure

A

Formerly called grand map seizure, this type of epilepsy is characterized by a series of generalized movements of tonic (stiffening) and clinic (rapid, synchronized jerking) muscular contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Unclassified seizures

A

Seizures that are not described by any of the seizure classifications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Akinesia

A

Reduction or lack of psychomotor captivity of voluntary muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Anticholinergic drugs

A

Drugs that block or impede the activity of the neurotransmitter acetylcholine (ACh) at cholinergic receptors in the brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Catechol ortho-methyltransferase (COMT) inhibitors

A

A class of indirect-acting dopaminergic drugs that work by inhibitions the enzymes COMT, which catalyzes the breakdown of dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Chorea

A

A condition characterized by involuntary, purposeless, rapid motions such as flexing and extending the fingers, raising and lowering the shoulders, or grimacing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Dopaminergic drugs

A

Drugs used to replace the deficiency of dopamine at dopamine receptors in the nerve endings, especially in the brain when treating Parkinson’s disease (can be direct- or indirect-acting or replacement drugs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Dyskinesia

A

An impaired ability to execute voluntary movements

48
Q

Dystonia

A

Impaired or distorted voluntary movement because of a disorder of muscle tone

49
Q

Endogenous

A

Describes any substance produced by the body’s own natural biochemistry (hormones, neurotransmitters)

50
Q

Exogenous

A

Describes any substance produced out f the body that may be taken into the body (medication, food, or an environmental toxin)

51
Q

On-off phenomenon

A

A phenomenon seen in patients taking levodopa long term, in which patients have periods of good control (“on” time) and those when they have bad control or breakthrough Parkinson’s disease (“off” time)

52
Q

Parkinson’s Disease (PD)

A

A slowly progressive, degenerative neurological disorder characterized by resting remora, pill-rolling of the fingers, mask like facies, shuffling gait, forward flexion of the trunk, loss of postural reflexes, and muscle rigidity and weakness

53
Q

Presynaptic drugs

A

Drugs that exert their antiparkinsonian effects before the nerve synapse

54
Q

Wearing-off phenomenon

A

A gradual worsening of parkinsonian symptoms as a patient’s medications begin to lose their effectiveness, despite maximal doses within a variety of medications

55
Q

Adjunct Therapy

A

Combination drug therapy used when a patient’s condition does not respond adequately to a single drug (monotherapy), or used when a given combination of medications is known to have therapeutic benefits over a single drug

56
Q

Affective disorders

A

Emotional disorders that are characterized by changes in mood

57
Q

Agoraphobia

A

Fear of leaving the familiar setting of home

58
Q

Akathisia

A

Motor restlessness. A distressing experience of uncontrollable muscular movements that can occur as an adverse effect of many psychotropic medications

59
Q

Antihistamine

A

Any substance capable of reducing the psychological and pharmacological effects of histamine, including a wide variety of drugs that block histamine receptors

60
Q

Antipsychotic

A

A medication that counteracts or diminishes symptoms of psychosis; also called a neuroleptic

61
Q

Anxiety

A

The unpleasant state of mind in which real or imagined dangers are anticipated or exaggerated

62
Q

Anxiolytic

A

Capable of reducing anxiety; usually said of a medication

63
Q

Benzodiazepine

A

A chemical category of drugs most frequently prescribed as sedative-hypnotic and anxiolytic drugs; the most common group of psychotropic drugs currently prescribed to alleviate anxiety

64
Q

Biogenic amine hypothesis (BAH)

A

Theory suggesting that depression and mania result from alterations in neuronal and synaptic amine concentrations, primarily the catecholamines dopamine and norepinephrine, as well as the indolamines serotonin and histamine

65
Q

Bipolar Disorder (BPD)

A

A major psychological disorder characterized by episodes of mania or hypomania, cycling with depression

66
Q

Depression

A

An abnormal emotional state characterized by exaggerated feelings of sadness, melancholy, dejection, worthlessness, emptiness, and hopelessness that are inappropriate and out of proportion to reality

67
Q

Dopamine Hypothesis

A

Theory that dopamine dysregulation in certain parts of the brain is one of the primary contributing factors to the development of psychotic disorders (psychoses)

68
Q

Dysregulation hypothesis

A

Theory that depression and affective disorders are not simply the result of decreased or increased catecholamine and serotonin activity but failures of the regulation of these systems

69
Q

Extrapyramidal Symptoms

A

Symptoms arising adjacent to the pyramidal portions of the brain

70
Q

Gamma-aminobutyric acid (GABA)

A

An inhibitory amino acid in the brain that functions to inhibit nerve transmission in the central nervous system

71
Q

Mania

A

A state characterized by an expansive emotional state; extreme excitement; excessive elation; hyperactivity; agitation; over talkativeness; flight of ideas; increased psychomotor activity; fleeting attention; and sometimes violent, destructive, and self-destructive behaviour

72
Q

Monoamine oxidase inhibitor (MAOI)

A

Any of a heterogeneous group of drugs used primarily in the treatment of depression

73
Q

Monotherapy

A

Pharmacological therapy involving a single medication for a specific condition

74
Q

Neurotransmitter

A

Endogenous chemical in the body that serves to conduct nerve impulses between nerve cells

75
Q

Psychosis

A

A syndrome consisting of a cluster of manifestations commonly associated with one or more mental health disorders

76
Q

Psychotherapeutics

A

The therapy of emotional and mental health disorders, which may involve drug therapy (pharmacotherapy), a variety of counselling techniques, recreational therapy, and, in extreme cases, electroconvulsive therapy (ECT)

77
Q

Psychotropic

A

Capable of affecting mental processes; usually said of a medication

78
Q

Selective serotonin reuptake inhibitor (SSRI)

A

Any of a heterogeneous group of newer medications used to treat depression and certain mental health disorders and that work by selectively reducing postsynaptic reuptake of the neurotransmitter serotonin in the brain; also called serotonin selective reuptake inhibitor

79
Q

Stigma

A

Widespread negative perceptions of and prejudice toward a specific group of people such as those with mental health disorders

80
Q

Tardive dyskinesia

A

A serious drug adverse effect involving disordered body movements and muscle tension that is associated with antispychotic medications

81
Q

Tricyclic antidepressants (TCAs)

A

A chemical class of antidepressant drugs with a distinctive three-ring segment in their chemical structure and that are used to block reuptake of the amine neurotransmitters serotonin and norepinephrine

82
Q

Amphetamines

A

CNS stimulants that produce mood elevation or euphoria, increase mental alertness and capacity to work, decrease fatigue and drowsiness, and prolong wakefulness

83
Q

Analeptics

A

CNS stimulants that have generalized effects on the brainstem and spinal cord, which, in turn, produce an increase in responsiveness to external stimuli and stimulate respiration

84
Q

Anorexiants

A

Drugs used to control or suppress appetite that also stimulate the CNS

85
Q

ADHD (Attention deficit hyperactivity disorder)

A

Syndrome affecting children, adolescents, and adults that involves difficulty maintaining concentration on a given task, hyperactive behaviour, or both

86
Q

Cataplexy

A

A condition characterized by abrupt attacks of muscular weakness and hypotonia trigged by an emotional stimulus such as joy, laughter, anger, fear, or surprise

87
Q

CNS stimulants

A

Drugs that stimulate specific areas of the brain or spinal cord

88
Q

Migraine

A

A common type of recurring painful headache characterized by a pulsatile or throbbing quality, incapacitating pain, and photophobia

89
Q

Narcolepsy

A

Syndrome characterized by sudden sleep attacks, cataplexy, sleep paralysis, and vial or auditory hallucinations at the onset of sleep

90
Q

Serotonin receptor agonists

A

A new class of CNS stimulants used to treat migraines that work by stimulating 5-HT, receptors in the brain and are sometimes referred to as selective serotonin receptor agonists or triptans

91
Q

Sympathomimetic drugs

A

CNS stimulants such as nor-adrenergic drugs whose actions resemble or mimic those of the sympathetic nervous system

92
Q

Drug Therapy for PD (Parkinson’s Disease)

A 
Anticholinergic drugs (Benztropine)
Antihistamines (diphenhydramine)
Dopamine receptor agonists - direct acting (bromocriptine, levodopa, levodopa-carbidopa)
Indirect- acting dopamine recetor agonists (MAO-B [monomaine oxidase B] inhibitor or selegilline, COMT [catechol orthomethyltransferase] inhibit or entacapone, Misc. drugs (amantadine [Symmetrel])
93
Q

Dopaminergic Therapy

A

Dopaminergic drugs are used to provide exogenous replacement of the lost dopamine or to enhance the function of the few neurons that are still producing their own dopamine

94
Q

Levodopa Therapy

A

As PD progresses, it becomes more and more difficult to control with levodopa
Ultimately, levodopa no longer controls the PD, and patient is seriously debilitated (this generally occurs between 5-10 years after the start of levodopa therapy)

95
Q

Dopaminergic Therapy: Replacement drugs (presynaptic)

A

These drugs work presynaptically to increase brain levels of dopamine
Levodopa is able to cross the BBB; then it is converted to dopamine. However, the large doses of levodopa needed to get dopamine to the brain also cause adverse effects

96
Q

Dopaminergic Therapy: Replacement drugs (presynaptic)

A

Carbidopa is given with levodopa to prevent levodopa breakdown in the periphery
As a result, more levodopa crosses the BBB, where it can be converted to dopamine

97
Q

Dopaminergic Therapy: Indirect acting (amantadine [Symmetrel])

A

Causes release of dopamine from the storage sites at the end of nerve cells that are still intact
Blocks the reuptake of dopamine into the nerve endings, allowing more to accumulate both centrally and peripherally
Does not stimulate dopamine receptors directly

98
Q

Anticholinergic Therapy

A

Anticholinergics block the effects of ACh
They are used to treat muscle tremors and muscle rigidity associated with PD, two symptoms caused by excessive cholinergic activity
They do not relieve bradykinesia (extremely slow movements)

99
Q

Anticholinergic Therapy

A

ACh accumulates because of the imbalance of dopamine
As a result, overstimulation of the cholinergic excitatory pathways occurs (muscle tremors and muscle rigidity; Cogwheel rigidity; Pill-rolling movement of fingers and head bobbing while at rest)

100
Q

Dopaminergic Therapy: Indirect acting (COMT inhibitors)

A

Inhibit COMT; the enzyme responsible for the breakdown of levodopa, the dopamine precursor

101
Q

Dopaminergic Therapy: Indications

A

Dopaminergic drugs are used to increase dopamine levels in the brain and to reduce the severity of PD symptoms
Amantadine (Symmetrel) also have antiviral effects

102
Q

Anticholinergic Drugs Used for PD

A

Benztropine mesylate
Trihexyphenidyl (Trihexyphen)
Procyclidine hydrochloride

103
Q

Anticholinergic Therapy: Indications

A

Used in the treatment of PD to cause smooth muscle relaxation, resulting in reduced muscle rigidity and akinesia
Also used to treat drug-induced extrapyramidal reactions to certain antipsychotic drugs

104
Q

Selegiline: Indications

A

Used in combination with levodopa or levodopa-carbidopa
Used as an adjunctive when a patient’s response to levodopa is fluctuating
Allows the dose of levodopa to be decreased; delays the development of unresponsiveness to levodopa therapy
The addition of selegiline commonly results in improvement in functional ability and decreased severity of symptoms
Pophylactic selegiline may delay the development of serious debilitating PD for 9-18 years

105
Q

Anticholinergic Therapy: Adverse Effects

A 
Drowsiness, confusion, disorientation
Constipation, N/V
Urinary retention, pain on urination
Blurred vision, dilated pupils, photophobia, dry skin
Decreased salivation, dry mouth
106
Q

Selegiline: Adverse Effects

A

Usually mild and include: N, lightheadedness, dizziness, abdominal pain, insomnia, confusion, dry mouth
Doses higher than 10mg/day may cause more severe adverse effects, such as hypertensive crisis

107
Q

Selective MAOI Therapy: Selgiline

A

MAOIs break down catecholamines in the CNS, primarily the brain
Selegiline is a newer, potent, irreversible MAOI that selectively inhibits MAO-B
If 10 mg or less is used, it does not elicit the “cheese effect” tyramine-containing foods of the nonselective MAOIs used to treat depression
Selegiline causes an increase in the levels of dopaminergic stimulation in the CNS

108
Q

Antiparkinsonian Drugs: Nursing Implications

A

Perform a thorough assessment, nursing history, and medication history
Include questions about the patients: CNS; Psychological emotional status
Assess for S&S of PD: mask-like expression; speech problems; dysphagia; rigidity of arms, legs, neck

109
Q

Antiparkinsonian Drugs: Nursing Implications

A

Provide patient education regarding PD and the medication therapy
Inform patient not to take other medications with PD drugs unless he or she checks with physician
When starting dopaminergic drugs, assist patient with walking because dizziness may occur
Oral doses should be given to minimize GI upset
Encourage patient to force fluids to at least 2000 mL/day (unless contraindicated)

110
Q

Antiparkinsonian Drugs: Nursing Implications

A

Monitor for response to drug therapy:

  • Improved sense of well-being and mental status
  • Increased appetite
111
Q

Antiparkinsonian Drugs: Nursing Implications

A

Pyridoxine (VB6) in doses greater than 10 mg will reverse the effects of levodopa
Teach patient to avoid foods high in VB6
Taking levodopa with MAOIs may result in hypertensive crisis
Patients should be told not to discontinue antiparkinsonian drugs suddenly
Teach patients about what therapeutic and adverse effects to expect with antiparkinsonian drug therapy

112
Q

Antiparkinsonian Drugs: Nursing Implications

A

Levodopa preparations may darken the patient’s urine and sweat
Therapeutic effects of COMT inhibitors may be noticed within a few days; it may take weeks with other drugs
Review the concept of “drug holidays” with patients using levodopa long term

113
Q

Antiepileptic Drugs

A

Antiepileptic drugs (AEDs) are also known as anticonvulsants
Goals of drug therapy include: to control or prevent seizures while maintaining a reasonable QOL; to minimize adverse effects and drug-induced toxicity
AED therapy is usually lifelong
A combination of drugs may be used
Single-drug therapy is tried before two-drug or multiple-drug therapy is implemented
Serum drug concentrations must be measured

114
Q

AED: Mechanism of Action

A

AED Therapy must:
- Prevent generation and spread of excessive electrical discharge from abnormally functioning nerve cells
- Protect surrounding normal cells
Exact mechanism of action is not known
AEDs are thought to alter the movement of Na+, K+, and Ca- ions across nerve cells in the brain
- Reduce nerve’s ability to be stimulated
- Suppress transmission of impulses from one nerve to the next
- Decrease the speed of nerve impulse conduction within a neuron

115
Q

AED: Mechanism of Action

A

Primary pharmacological effects of AED

  • Increase threshold of activity in the brain motor activity
  • Act to depress or limit the spread of seizure discharge from its origin
  • They can decrease the speed of nerve impulse conduction within a given neuron

Pharm II (5 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions